|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.476
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.389
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.376
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.353
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.327
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.310
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.271
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.264
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.249
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.214
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.213
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.208
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.207
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.200
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.197
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.192
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.178
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.175
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.171
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.167
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.163
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.159
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.157
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.154
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.152
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.151
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.149
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.149
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.145
|
|
|
|
hypotonic response
|
GO:0006971 |
3 |
0.143
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.143
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.142
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.135
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.132
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.132
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.131
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.130
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.130
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.126
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.126
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.125
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.124
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.121
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.120
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.116
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.113
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.112
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.112
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.111
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.110
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.108
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.108
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.107
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.104
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.104
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.104
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.103
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.102
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.100
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.099
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.096
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.095
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.095
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.095
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.095
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.092
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.091
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.091
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.091
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.091
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.090
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.089
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.089
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.088
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.088
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.087
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.087
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
31 |
0.087
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.087
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.087
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.086
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.085
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.085
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.085
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.084
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.084
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.083
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.081
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.080
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.080
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.079
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.079
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.079
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.078
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.078
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.078
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.078
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.078
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.077
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.077
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.077
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.076
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.076
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.076
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.076
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.075
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.074
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.073
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.073
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.073
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.073
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.072
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.072
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.072
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.072
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.071
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.071
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.071
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.070
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.070
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.070
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.070
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.070
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.070
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.068
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.068
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.068
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.067
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.066
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.066
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.065
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.065
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.065
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.064
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.064
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.064
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.062
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.062
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.062
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.062
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.062
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.061
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.061
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.061
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.061
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.061
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.060
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.060
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.059
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.059
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.059
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.059
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.059
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.058
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.058
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.058
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.058
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.058
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.057
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.057
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.057
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.056
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.056
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.055
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.055
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.055
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.055
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.054
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.054
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.053
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.053
|
|
|
|
peptidyl threonine modification
|
GO:0018210 |
31 |
0.053
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.053
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.053
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.053
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.053
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.052
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.052
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.052
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.051
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.051
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.051
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.051
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.051
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.051
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.051
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.050
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.050
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.050
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.050
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.049
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.049
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.049
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.049
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.048
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.048
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.048
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.048
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.048
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.048
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.048
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.047
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.047
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.047
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.046
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.046
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.046
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.046
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.046
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.046
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.045
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.045
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.045
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.045
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.045
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.044
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.044
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.044
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.044
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.044
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.044
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.043
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.043
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.043
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.043
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.043
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.043
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.043
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.043
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.042
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.042
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.042
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.042
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.042
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.042
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.042
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.042
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.042
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.041
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.041
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.041
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.041
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.041
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.041
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.041
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.040
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.040
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.040
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.040
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.040
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.039
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.039
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.039
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.039
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.039
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.038
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.038
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.038
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.038
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.038
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.038
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.038
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.037
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.037
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.037
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.037
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.037
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.037
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.037
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.037
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.036
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.036
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.036
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.036
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.036
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.036
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.036
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.036
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.036
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.036
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.036
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.036
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.036
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.036
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.036
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.036
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.035
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.035
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.035
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.035
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.035
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.035
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.035
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.035
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.035
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.035
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.035
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.034
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.034
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.034
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.034
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.034
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.034
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.034
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.034
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.034
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.034
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.034
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.034
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.034
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.034
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.034
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.034
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.034
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.033
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.033
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.033
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.033
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.033
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.033
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.033
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.033
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.033
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.033
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.033
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.033
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.033
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.033
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.032
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.032
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.032
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.032
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.032
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.032
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.032
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.032
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.032
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.032
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.032
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.031
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.031
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.031
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.031
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.031
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.031
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.031
|
|
|
|
regulation of actin filament bundle assembly
|
GO:0032231 |
18 |
0.031
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.031
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.031
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.031
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.031
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.031
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.031
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.031
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.031
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.031
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.030
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.030
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.030
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.030
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.030
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.030
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.030
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.030
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.029
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.029
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.029
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.029
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.029
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.029
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.029
|
|
|
|
negative regulation of muscle cell differentiation
|
GO:0051148 |
33 |
0.029
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.029
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.029
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.029
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.029
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.029
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.028
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.028
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.028
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.028
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.028
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.028
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.028
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.028
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.028
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.028
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.028
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.028
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.028
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.028
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.028
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.028
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.027
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.027
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.027
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.027
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.027
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.027
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.027
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.027
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.027
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.027
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.027
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.027
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.027
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.026
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.026
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.026
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.026
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.026
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.026
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.026
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.026
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.026
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.026
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.026
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.026
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.026
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.026
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.026
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.026
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.026
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.026
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.026
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.026
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.025
|
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.025
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.025
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.025
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.025
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.025
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.025
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.025
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.025
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.025
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.025
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
14 |
0.025
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.025
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.025
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.025
|
|
|
|
regulation of non canonical wnt signaling pathway
|
GO:2000050 |
12 |
0.024
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.024
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.024
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.024
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.024
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.024
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.024
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.024
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.024
|
|
|
|
positive regulation of smooth muscle cell differentiation
|
GO:0051152 |
2 |
0.024
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.024
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.024
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.024
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.024
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.024
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.024
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.024
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.024
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.024
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.023
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.023
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.023
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.023
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.023
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.023
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.023
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.023
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.023
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.023
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.023
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.023
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.023
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.023
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.023
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.023
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.023
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.023
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.023
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.023
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.022
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.022
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.022
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.022
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.022
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.022
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.022
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.022
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.022
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.022
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.022
|
|
